The challenges of implementing pharmacogenomic testing in the clinic

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Introduction: Pharmacogenomic testing has the potential to greatly benefit patients by enabling personalization of medication management, ensuring better efficacy and decreasing the risk of side effects. However, to fully realize the potential of pharmacogenomic testing, there are several important issues that must be addressed. Areas covered: In this expert review we discuss current challenges impacting the implementation of pharmacogenomic testing in the clinical practice. We emphasize issues related to testing methods, reporting of the results, test selection, clinical interpretation of the results, cost-effectiveness, and the long-term use of pharmacogenomic results in clinical practice. We identify opportunities and future directions to facilitate clinical implementation. Expert commentary: Several key elements are necessary to optimally integrate pharmacogenomic testing into clinical practice. Collaborative efforts among laboratories are needed to improve standardization of testing and reporting of the results. Clinicians need educational opportunities to improve understanding of which test to order and how to interpret the results. The electronic health records and other clinical systems need to improve their storage of the pharmacogenomics test results and interoperability to facilitate the use of clinically actionable results to improve patient care.

Original languageEnglish (US)
Pages (from-to)567-577
Number of pages11
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume17
Issue number6
DOIs
StatePublished - Nov 2 2017

Fingerprint

Pharmacogenetics
Electronic Health Records
Cost-Benefit Analysis
Patient Care
Pharmacogenomic Testing
Direction compound

Keywords

  • Clinical practice
  • genetic testing
  • pharmacogenomic testing
  • pharmacogenomics
  • precision medicine

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Cite this

The challenges of implementing pharmacogenomic testing in the clinic. / Moyer, Ann; Caraballo, Pedro.

In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 17, No. 6, 02.11.2017, p. 567-577.

Research output: Contribution to journalReview article

@article{1d6cea74dfe540caab2c96720d4841bf,
title = "The challenges of implementing pharmacogenomic testing in the clinic",
abstract = "Introduction: Pharmacogenomic testing has the potential to greatly benefit patients by enabling personalization of medication management, ensuring better efficacy and decreasing the risk of side effects. However, to fully realize the potential of pharmacogenomic testing, there are several important issues that must be addressed. Areas covered: In this expert review we discuss current challenges impacting the implementation of pharmacogenomic testing in the clinical practice. We emphasize issues related to testing methods, reporting of the results, test selection, clinical interpretation of the results, cost-effectiveness, and the long-term use of pharmacogenomic results in clinical practice. We identify opportunities and future directions to facilitate clinical implementation. Expert commentary: Several key elements are necessary to optimally integrate pharmacogenomic testing into clinical practice. Collaborative efforts among laboratories are needed to improve standardization of testing and reporting of the results. Clinicians need educational opportunities to improve understanding of which test to order and how to interpret the results. The electronic health records and other clinical systems need to improve their storage of the pharmacogenomics test results and interoperability to facilitate the use of clinically actionable results to improve patient care.",
keywords = "Clinical practice, genetic testing, pharmacogenomic testing, pharmacogenomics, precision medicine",
author = "Ann Moyer and Pedro Caraballo",
year = "2017",
month = "11",
day = "2",
doi = "10.1080/14737167.2017.1385395",
language = "English (US)",
volume = "17",
pages = "567--577",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - The challenges of implementing pharmacogenomic testing in the clinic

AU - Moyer, Ann

AU - Caraballo, Pedro

PY - 2017/11/2

Y1 - 2017/11/2

N2 - Introduction: Pharmacogenomic testing has the potential to greatly benefit patients by enabling personalization of medication management, ensuring better efficacy and decreasing the risk of side effects. However, to fully realize the potential of pharmacogenomic testing, there are several important issues that must be addressed. Areas covered: In this expert review we discuss current challenges impacting the implementation of pharmacogenomic testing in the clinical practice. We emphasize issues related to testing methods, reporting of the results, test selection, clinical interpretation of the results, cost-effectiveness, and the long-term use of pharmacogenomic results in clinical practice. We identify opportunities and future directions to facilitate clinical implementation. Expert commentary: Several key elements are necessary to optimally integrate pharmacogenomic testing into clinical practice. Collaborative efforts among laboratories are needed to improve standardization of testing and reporting of the results. Clinicians need educational opportunities to improve understanding of which test to order and how to interpret the results. The electronic health records and other clinical systems need to improve their storage of the pharmacogenomics test results and interoperability to facilitate the use of clinically actionable results to improve patient care.

AB - Introduction: Pharmacogenomic testing has the potential to greatly benefit patients by enabling personalization of medication management, ensuring better efficacy and decreasing the risk of side effects. However, to fully realize the potential of pharmacogenomic testing, there are several important issues that must be addressed. Areas covered: In this expert review we discuss current challenges impacting the implementation of pharmacogenomic testing in the clinical practice. We emphasize issues related to testing methods, reporting of the results, test selection, clinical interpretation of the results, cost-effectiveness, and the long-term use of pharmacogenomic results in clinical practice. We identify opportunities and future directions to facilitate clinical implementation. Expert commentary: Several key elements are necessary to optimally integrate pharmacogenomic testing into clinical practice. Collaborative efforts among laboratories are needed to improve standardization of testing and reporting of the results. Clinicians need educational opportunities to improve understanding of which test to order and how to interpret the results. The electronic health records and other clinical systems need to improve their storage of the pharmacogenomics test results and interoperability to facilitate the use of clinically actionable results to improve patient care.

KW - Clinical practice

KW - genetic testing

KW - pharmacogenomic testing

KW - pharmacogenomics

KW - precision medicine

UR - http://www.scopus.com/inward/record.url?scp=85032959933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032959933&partnerID=8YFLogxK

U2 - 10.1080/14737167.2017.1385395

DO - 10.1080/14737167.2017.1385395

M3 - Review article

C2 - 28949250

AN - SCOPUS:85032959933

VL - 17

SP - 567

EP - 577

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 6

ER -